0001209191-15-046721.txt : 20150526 0001209191-15-046721.hdr.sgml : 20150525 20150526164035 ACCESSION NUMBER: 0001209191-15-046721 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150522 FILED AS OF DATE: 20150526 DATE AS OF CHANGE: 20150526 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc. CENTRAL INDEX KEY: 0001503802 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263931704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-658-0600 MAIL ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dolsten Mikael CENTRAL INDEX KEY: 0001437590 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 15889854 MAIL ADDRESS: STREET 1: 5 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-05-22 0 0001503802 Karyopharm Therapeutics Inc. KPTI 0001437590 Dolsten Mikael C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE NEWTON MA 02459 1 0 0 0 Nonstatutory Stock Option (right to buy) 26.15 2015-05-22 4 A 0 10000 0.00 A 2025-05-21 Common Stock 10000 10000 D This option vests as to 100% of the underlying shares on May 22, 2016, provided that the holder continues to serve as a director of the issuer through such date. /s/Christopher B. Primiano, Attorney-in-Fact for Mikael Dolsten 2015-05-26